Meyka Pro banner
Aditxt, Inc.

Aditxt, Inc. (ADTX) Stock Overview

Explore Aditxt, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ADTXPNK
HealthcareBiotechnology
$0.004
$0.00(2.86%)
U.S. Market opens in 22h 22m

Aditxt, Inc. (ADTX)

Meyka AI Score

Z

Key Financials

Market Cap3.7M
P/E Ratio-0.00
EPS (TTM)$-40.75
ROE9.26%
Fundamental Analysis

AI Price Forecasts

1 Month$1.30
3 Months$3.13
1 Year Target$0.00

ADTX Stock Analysis & Investment Overview (PNK)

Our AI-powered analysis of Aditxt, Inc. (PNK: ADTX) gives investors deep insight into how the stock performs on the PNK exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Aditxt, Inc.'s PNK-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ADTX on the PNK shows an RSI of 5.89, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the PNK listing.

Key metrics behind Aditxt, Inc.'s PNK-traded stock include a P/E ratio of -0.00 and a market capitalization of 3.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ADTX on the PNK.

Price Performance (PNK: ADTX)

1-Day Change
N/A
5-Day Change
34.62%
1-Month Change
-63.16%
3-Month Change
-99.95%
6-Month Change
-100.00%
Year-to-Date (YTD) Change
-100.00%
1-Year Change
-100.00%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

650 870 1200
2569 Wyandotte Street, Mountain View, CA, 94043

Company Facts

260 Employees
IPO DateJun 30, 2020
CountryUS
Actively Trading

Frequently Asked Questions